Alchemy Labs Inc.

As of June 30, 2026, Alchemy Labs Inc. has 54.56M shares outstanding.

As of June 30, 2026, Alchemy Labs Inc. maintains a current ratio of 0.26, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -141.71, indicating conservative leverage, while an interest coverage ratio of -2.30 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Alchemy Labs Inc. recorded an income tax benefit of -2,721.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -6.96M and -6.95M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

These figures are as of the close on October 22, 2026.

Over the twelve months ended June 30, 2026, Alchemy Labs Inc. generated 1.47M in revenue and converted that into -6.95M in net income, yielding earnings per share of -0.13. EBITDA reached -4.28M, while operating income came in at -4.58M.

As of June 30, 2026, Alchemy Labs Inc. holds 1.26M in cash and equivalents against 8.76M in total debt, resulting in a net debt position of 7.34M. Total book value stands at -6.18M, with working capital of -8.63M providing operational flexibility.

Alchemy Labs Inc. produced -4.26M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.65M in capital expenditures, free cash flow totaled -5.91M - equivalent to -0.11 per share.

Over the twelve months ended June 30, 2026, Alchemy Labs Inc. posted a gross margin of 12.02, reflecting its pricing power and cost economics. The operating margin of -310.35 and net profit margin of -471.69 provide insight into operational efficiency.